New FDA Draft Guidance on Responding to 483 Observations; What Drug Manufacturers Need to Know Now
By Eric L. Foxman, Pharm. (Ret.) In March 2026, FDA released a significant draft guidance which presents consolidated and formalized expectations for drug manufacturers responses to FDA Form 483 Inspection…
Read MoreStability Testing
By Mark Land, M.S., RAC-US, AAHP President When I think back to my early days in homeopathy, I recall that in the manufacturing facility there was a paper copy of the…
Read MoreBranding Part II: How to Create a Motivating, Sustainable Brand Positioning / Strategy
By Cynthia Batterman This article originally appeared in the October 2011 hardcopy-only edition of the AAHP Network News. Building upon a previous article on the importance of a brand positioning…
Read MoreBranding Part I: A Positioning Statement Is Mission Critical to Your Business
By Cynthia Batterman This article originally appeared in the August 2011 hardcopy-only edition of the AAHP Network News. One of the most important strategic projects that any company can pursue is the development of its…
Read MoreUsing AI-Powered Sentiment Analysis to Strengthen Marketing and Differentiation in Homeopathic Products
By Brenda van Goethem, Director of Regulatory Compliance and Change Management at Nature’s Way Brands, LLC (Schwabe North America) and AAHP Board of Director Artificial intelligence (AI) is rapidly reshaping…
Read MoreMarketing of Homeopathic Drug Products: OTC vs. Rx-only
By Eric L. Foxman, Pharm. (Ret.) On a single day in mid-November, FDA issued five warning letters* to a like number of distributors / manufacturers of homeopathic drug products. The cause? The firms were cited because “the…
Read MoreHonor The Basics
By Mark Land, M.S., RAC-US, AAHP President In this issue, we examine marketing of homeopathic drug products. As I read through the articles, what consistently came to mind was that the basics matter. The principles that former AAHP…
Read MoreMeasles and OTC Homeopathic Treatment: AAHP’s Position
As reported outbreaks of measles have risen in the U.S. recently, AAHP reminds manufacturers and marketers that Federal law prohibits the sale of products—homeopathic or otherwise—directly to consumers for the…
Read MoreAAHP 2026 Outlook
By Mark Land, M.S., RAC-US, AAHP President Building on lessons learned in previous years and focusing our attention on the issues of our industry and our members, the Board has…
Read MoreSupporting Volunteers, Securing the Future: The Role of Professional Management at AAHP
By Emily Leonczyk, MBA, CAE, President & CEO of The Markens Group For me, the start of a new year invites a welcome pause, reflections over a slow cup of coffee,…
Read More